KEVZARA

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 65976ada2b8bb809
Drug Approval Canada Name: KEVZARA
Product Name: KEVZARA
Status: Cancelled Post Market
Status Date: 2022-08-02
Original Market Date: 2017-03-29
Din: 02460521
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 90:24.20.92
Atc Original: L04AC14 SARILUMAB
Atc Name: l 04 ac 14
Aig Number: 0158770001
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

SARILUMAB

150 MG / 1.14 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

65976ada2b8bb809

Type

Standard